Adar Poonawalla - Latest News Update, Information, Photos & Videos on Adar Poonawalla at Lokmat Times

Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Tuesday said that they are working towards developing a vaccine booster shot which is more effective against Omicron virus.Poonawalla said that on the basis of enough data, it is safe to say that booster vaccines are a proven strategy to increase antibodies to a great extent.COVID vaccines for children aged above 3 years will be launched in the next 6 months, Poonawala said."After two years of the pandemic, India is now better prepared to deal with such catastrophe, and hopefully the worst is behind us all. The Government of India has been working towards creating an effective healthcare system and has made enough provision for hospital beds and oxygen," Adar Poonawalla said at the CII Partnership Summit 2021, organised in association with Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry.He said that with over a billion-dollar investment that has gone into developing and manufacturing the COVID-19 vaccine, the journey so far has given us several key lessons owing to the rapidly changing situation in accordance with the mutating virus.Poonawalla said that globally, the supply of vaccines has outmatched its demand. "To keep up with the momentum, countries need to come together and form some agreement in order to prepare standard rules for clinical trials and manufacturing of the vaccines. Multilateral organisations and policy makers should be able to identify and isolate the new mutation/s and find out the efficacy of vaccine against it, in a time bound manner. Joining two other companies which are working towards developing the vaccine for children, SII has reached the trial phase of the vaccine for the children aged above 3. It should be ready within the next 6 months," he said. Commending the Government of India's role in tackling the challenges posed by the pandemic in the last two years, he stated that going forward, Government and industry should work even more closely to further improve the business environment and simplify the rules and regulations for manufacturers to expand the sector.Rajan Navani, Chairman, CII's India@75 Council and Vice Chairman and Managing Director, Jetline Industries, noted that Omicron has created fresh challenges for the world. He referred to CII's India@75 campaign which has been working on several areas since 2008.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Adar PoonawallaFOLLOW

Adar poonawalla, Latest News

Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII) has made an important statement regarding the ... ...

Amid the overall cases and positivity rate declining in the country and states like Maharashtra, West Bengal and Himachal Pradesh revoking the COVID restrictions, Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII), prais ...

Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India. ...

The ongoing vaccination campaign in the country has so far been dominated by Covishield and Bharat Biotech's Covaxin. Adar ... ...

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, on Tue ...

The country is witnessing an increase in cases of coronavirus infection. The Delta variant of the Corona had caused ... ...

New York, Dec 17 Novavax's Covid-19 vaccine is 90 per cent effective at preventing Covid-19 illness, according to ... ...

Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Tuesday said that they are working towards developing a vaccine booster shot which is more effective against Omicron virus. ...